New lupus drug CLN-978 enters early human testing
NCT ID NCT06613360
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug called CLN-978 in 24 people with moderate to severe lupus. The main goal is to see if the drug is safe and tolerable. Researchers will also measure how the drug moves through the body and how it affects immune cells. This is a first step to see if CLN-978 might help control lupus symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SLE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AARA Clinical Research
RECRUITINGAvondale, Arizona, 85392, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
AARA Clinical Research
RECRUITINGTucson, Arizona, 85704, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
ARENSIA Exploratory Medicine S.R.L.
RECRUITINGBucharest, 011658, Romania
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
ARENSIA Exploratory Medicine, LLC
RECRUITINGTbilisi, 0112, Georgia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Arensia Exploratory Medicine
RECRUITINGCluj-Napoca, 400006, Romania
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU de Nantes
RECRUITINGNantes, 44093, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Centre Hospitalier Universitaire de Toulouse
RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Columbia University Medical Center
RECRUITINGNew York, New York, 10032, United States
-
Intermountain Health
RECRUITINGSalt Lake City, Utah, 84101, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Multi profile Hospital for Active Treatment Sveta Sofia
RECRUITINGSofia, 1618, Bulgaria
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Omega Research Group
RECRUITINGOrlando, Florida, 32808, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Osteoporosis Solutions
RECRUITINGVictoria Park, 6100, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Regional One Health
RECRUITINGMemphis, Tennessee, 38103, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Royal Melbourne Hospital
RECRUITINGParkville, 3050, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Stryde Research
RECRUITINGPlano, Texas, 75093, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Timofei Moșneaga Republican Clinical Hospital
WITHDRAWNChisinau, 2025, Moldova
-
Tranquil Clinical Research
RECRUITINGWebster, Texas, 77598, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Saint Etienne
RECRUITINGSaint-Priest-en-Jarez, 42270, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Iowa
RECRUITINGIowa City, Iowa, 52242, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Rochester Medical Center
RECRUITINGRochester, New York, 14642, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New lupus drug CUG252 passes first safety check in small trial
- Community leaders step up to boost COVID shots in black rheumatic patients
- Lupus pain drug shows promise in early trial
- New lupus drug candidate ISH0613 enters first human safety trial
- New lupus pill shows promise in Mid-Stage trial
- Engineered immune cells take on lupus in first human test